Market closed
Embecta Corp./$EMBC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Embecta Corp.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Ticker
$EMBC
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
2,200
Website
Embecta Corp. Metrics
BasicAdvanced
$882M
Market cap
12.73
P/E ratio
$1.20
EPS
0.95
Beta
$0.60
Dividend rate
3.92%
Dividend yield
Price and volume
Market cap
$882M
Beta
0.95
52-week high
$19.79
52-week low
$9.93
Average daily volume
286K
Dividend rate
$0.60
Financial strength
Current ratio
2.107
Quick ratio
1.402
Long term debt to equity
-212.295
Total debt to equity
-213.985
Dividend payout ratio (TTM)
49.35%
Interest coverage (TTM)
1.75%
Management effectiveness
Return on assets (TTM)
9.64%
Return on equity (TTM)
-8.86%
Valuation
Price to earnings (TTM)
12.726
Price to revenue (TTM)
0.787
Price to book
-1.15
Price to tangible book (TTM)
-1.12
Price to free cash flow (TTM)
64.242
Dividend yield (TTM)
3.92%
Forward dividend yield
3.92%
Growth
Revenue change (TTM)
0.48%
Earnings per share change (TTM)
45.34%
What the Analysts think about Embecta Corp.
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Embecta Corp. stock.
Embecta Corp. Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Embecta Corp. Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Embecta Corp. News
AllArticlesVideos
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
GlobeNewsWire·1 day ago
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
GlobeNewsWire·2 months ago
embecta to Participate in Investor Events
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Embecta Corp. stock?
Embecta Corp. (EMBC) has a market cap of $882M as of November 08, 2024.
What is the P/E ratio for Embecta Corp. stock?
The price to earnings (P/E) ratio for Embecta Corp. (EMBC) stock is 12.73 as of November 08, 2024.
Does Embecta Corp. stock pay dividends?
Yes, the Embecta Corp. (EMBC) stock pays dividends to shareholders. As of November 08, 2024, the dividend rate is $0.6 and the yield is 3.92%. Embecta Corp. has a payout ratio of 49.35% on a trailing twelve-month basis.
When is the next Embecta Corp. dividend payment date?
The next Embecta Corp. (EMBC) dividend payment date is unconfirmed.
What is the beta indicator for Embecta Corp.?
Embecta Corp. (EMBC) has a beta rating of 0.95. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.